• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 916ESA
Device Problems Peeled/Delaminated (1454); Deformation Due to Compressive Stress (2889); Physical Resistance/Sticking (4012)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/16/2021
Event Type  Injury  
Manufacturer Narrative
The investigation is in progress.A supplemental report will be submitted.
 
Event Description
Edwards received notification from a thv territory manager that during a right transfemoral tavr, there was resistance during insertion of the 29mm sapien 3 valve into the 16fr esheath.Fluoro images showed that the esheath was perforated and the devices were surgically removed.As reported, the patient had severe tortuosity in external iliac artery.Multiple sheaths were required to ultimately get up with the esheath.Once the esheath was placed, a 29mm commander delivery system was prepped and inserted into the esheath.Difficulty pushing the valve through the esheath was experienced and ultimately the esheath and delivery system were observed to be kinking.The delivery system was not moving forward though the esheath at the level of the external iliac artery.The difficulty was experienced approximately halfway into the esheath.Fluoro pictures seemed to show that the sheath was perforated.The undeployed thv appeared to be herniated through the side of the esheath.The system was unable to be advanced or removed.The procedure was stopped and vascular surgery was called.The patient remained stable and was taken to vascular or for surgical removal of the devices.The esheath was destroyed during surgical removal.There was no frame damage observed on the valve.No pictures are available and the devices are not available for return.The patient had a highly tortuous vessel with minimal lumen diameter (mld) at 5-5.5mm.
 
Manufacturer Narrative
The device was not available for return per the field clinical specialist.Therefore, a no product return engineering evaluation was performed.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.The complaints were unable to be confirmed as the device nor applicable imagery was provided.No manufacturing nonconformance was identified during the evaluation.A review of the device history records did not provide any indication that a manufacturing non-conformance would have contributed to the events.A detailed root cause analysis for similar returned sheath shaft resistance with delivery system complaints has been conducted and summarized in an edwards lifesciences technical summary.The technical summary provides details of contributing factors for increased resistance during insertion and advancement of the delivery system through the sheath.The following vessel characteristics and procedural factors were identified as the root causes for encountering increased resistance: tortuous vessels can create sub-optimal angles that can lead to non-axial alignment in the advancement of the delivery system.Complaint description states that the patient's access vessel was 'highly tortuous'.Calcification can reduce the vessel diameter and may increase restriction leading to resistance.Calcification can also result in the creation of sub-optimal angles during delivery system insertion that may lead to resistance.Undersized vessel can create a restricted pathway or constrained condition resulting in difficulty during sheath expansion, thereby increased resistance.The patient's minimal lumen diameter (mld) was 5-5.5mm, which is under the size necessary for safe use of the 16f esheath (greater than or equal to 6.0mm).Steep insertion angle can result in non-coaxial alignment between the delivery system and sheath, which may lead to resistance during advancement.Consequently, if high push was used to overcome the resistance, the sheath could buckle and kink.The technical summary also outlines the extensive manufacturing mitigations in place to detect a defect or nonconformance associated with an esheath resistance with delivery system.There are several 100% in-process inspections (visual) performed in manufacturing process and product verification testing (functional and visual) on a sampling plan basis performed prior to lot release.These inspections and testing support that it is unlikely that a manufacturing non-conformance contributed to the resistance advancing the delivery system into the sheath and the sheath kink.As such, available information suggests that patient factors (tortuosity and undersized vessel) and/or procedural factors (high push force) may have contributed to the reported event.No labeling or ifu inadequacies have been identified.Since no edwards defect was identified,no corrective or preventative action is required.Regarding the complaint of sheath liner torn, an existing edwards lifesciences technical summary has been documented for root cause analysis on sheath shaft liner tears with normal liner expansion.In this technical summary, a review of liner tear complaint investigations on returned devices over a two-year period found that patient and/or procedural factors (e.G., access vessel tortuosity, calcification, withdrawal of a burst or torn balloon) are likely the contributing factors for sheath shaft liner tears.The complaint description states that the patient's access vessel was 'highly tortuous'.Tortuous patient anatomy can create sub-optimal angles that can lead to non-axial alignment in the advancement of the delivery system.The delivery system can thereby catch on the sheath liner of the sheath resulting in a torn liner if high push force is used.The technical summary demonstrated that there were no deficiencies in the ifu/training manuals and that the mitigations in place during manufacturing support that it is unlikely that a manufacturing non-conformance contributed to the complaint.It should be noted that these mitigations (from manufacturing and the ifu/training manual), as identified in the technical summary, are still in place.Available information supports that patient factors (tortuosity) and/or procedural factors (high push force) likely led to the sheath liner tear and there is no evidence of device malfunction or manufacturing non-conformance.No labeling or ifu inadequacies have been identified.Since no edwards defect was identified, no corrective or preventative action is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH INTRODUCER SET
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key12611814
MDR Text Key277615659
Report Number2015691-2021-05623
Device Sequence Number1
Product Code NPT
UDI-Device Identifier00690103193992
UDI-Public(01)00690103193992(17)230510(10)63779116
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/10/2023
Device Model Number916ESA
Device Catalogue NumberN/A
Device Lot Number63779116
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/12/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-